Lv590
1120 积分 2021-07-02 加入
Physiologically Based Pharmacokinetic Model‐Informed Drug Development for Polatuzumab Vedotin: Label for Drug‐Drug Interactions Without Dedicated Clinical Trials
2天前
已完结
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2天前
已完结
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2天前
已完结
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
3天前
已关闭
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
3天前
已完结
Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling
14天前
已完结
Broad Immunomodulatory Effects of the Dipeptidyl-peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Place-controlled WILLOW Trial
19天前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
30天前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
30天前
已完结
Vitamin D Metabolites and Parathyroid Hormone in Cushing’s Syndrome: Relationship to Calcium and Phosphorus Homeostasis*
1个月前
已完结
皖公网安备34019202002308
